Peppermint Raises $4.7M Seed

Peppermint, a San Francisco-based software company, has announced a $4.7 million seed funding round to accelerate the development of its AI-powered financial operations platform for clinical research teams. The company aims to modernize the financial infrastructure used by hospital systems and research sites to manage clinical trials.

Investors

The funding round was led by Moxxie. Additional participating investors included Homebrew, Better Tomorrow Ventures, Layout Ventures, Digital Health Venture Partners, Night Capital, and angel investors Benjamin Mann and Evan Moore.

Peppermint Use of Funds

Peppermint plans to utilize the capital to expand its platform functionality beyond current collections capabilities. Planned features include budget negotiation, expense management, and clinical trial analytics to provide a comprehensive financial ledger for research operations.

About Peppermint

Founded in 2026 by David Freeman and VJ Thurimella, Peppermint provides an AI-powered financial operations platform designed for clinical research teams. The software integrates with existing clinical trial management systems to automate billing, invoicing, and collections, replacing manual processes with an auditable and precise revenue cycle management system.

Funding Details

Company Website: https://getpeppermint.ai

Company: Peppermint
Raised: $4.7M
Round: Seed
Funding Date: October 8, 2026
Lead Investor: Moxxie
Additional Investors: Homebrew, Better Tomorrow Ventures, Layout Ventures, Digital Health Venture Partners, Night Capital, Benjamin Mann, Evan Moore
Company Website: https://getpeppermint.ai
Software Category: FinTech
Source: https://www.businesswire.com/news/home/20261008554385/en/Peppermint-Raises-%244.7M-to-Bring-Scientific-Precision-to-the-Finances-of-Clinical-Research